FINWIRES · TerminalLIVE
FINWIRES

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,482,367, According to a Recent SEC Filing

By

Evan Lippman, Executive Vice President, Business Development, on May 14, 2026, sold 41,658 shares in Teva Pharmaceutical Industries (TEVA) for $1,482,367. Following the Form 4 filing with the SEC, Lippman has control over a total of 44,191 ordinary shares of the company, with 44,191 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000119312526228876/xslF345X05/ownership.xml

Related Articles